Identification of transcriptional regulators of neuropeptide FF gene expression

Peptides

Volumn 27, Issue 5, 2006, Pages 1020-1035

  Nystedt, Johanna M ^a,b   Brandt, Annika ^a   Vilim, Ferdinand S ^c   Ziff, Edward B ^d   Panula, Pertti ^a,b  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antiopioid; DREAM; NPFF; Pain; Promoter; RFamide

Indexed keywords

CALSENILIN; HOMEODOMAIN PROTEIN; LUCIFERASE; NEUROPEPTIDE FF; NUCLEAR PROTEIN; OCTAMER TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MEIS; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR PIT 1; UNCLASSIFIED DRUG; INSULIN PROMOTER FACTOR 1; KV CHANNEL INTERACTING PROTEIN; MYELOID ECOTROPIC VIRAL INTEGRATION SITE 1 PROTEIN; OLIGOPEPTIDE; PHENYLALANYL LEUCYL PHENYLALANYL GLUTAMINYL PROLYL GLUTAMINYL ARGINYL PHENYLALANINAMIDE; PHENYLALANYL-LEUCYL-PHENYLALANYL-GLUTAMINYL-PROLYL-GLUTAMINYL-ARGINYL-PHENYLALANINAMIDE; POU2F1 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TUMOR PROTEIN;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAY REGION BINDING SITE; CONTROLLED STUDY; DNA FLANKING REGION; EMBRYO DEVELOPMENT; FUNCTIONAL PROTEOMICS; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; INTRON; MALE; MOLECULAR BIOLOGY; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; ANIMAL; ANIMAL DISEASE; C57BL MOUSE; CENTRAL NERVOUS SYSTEM; CHROMOSOME MAP; COMPARATIVE STUDY; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; SEQUENCE ALIGNMENT;

MAMMALIA;

5' FLANKING REGION; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CENTRAL NERVOUS SYSTEM; CHROMOSOME MAPPING; CLONING, MOLECULAR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; KV CHANNEL-INTERACTING PROTEINS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; OCTAMER TRANSCRIPTION FACTOR-1; OLIGOPEPTIDES; RATS; SEQUENCE ALIGNMENT; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR PIT-1; TRANSCRIPTION FACTORS;

EID: 33746059071     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.07.029     Document Type: Article

References (47)

1. An W.F., Bowlby M.R., Betty M., Cao J., Ling H.P., Mendoza G., et al. Modulation of A-type potassium channels by a family of calcium sensors. Nature 403 (2000) 553-556
2. Andersen B., and Rosenfeld M.G. Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J Biol Chem 269 (1994) 29335-29338
3. Arima H., Murase T., Kondo K., Iwasaki Y., and Oiso Y. Centrally administered neuropeptide FF inhibits arginine vasopressin release in conscious rats. Endocrinology 137 (1996) 1523-1529
4. Askwith C.C., Cheng C., Ikuma M., Benson C., Price M.P., and Welsh M.J. Neuropeptide FF and FMRFamide potentiate acid-evoked currents from sensory neurons and proton-gated DEG/ENaC channels. Neuron 26 (2000) 133-141
5. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., et al. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem 275 (2000) 39324-39331
6. Burke J.F., Clarke A.J.H., James M.R., and Perry S.J. Physical mapping of the human NPFF gene and investigation of its candidacy as a disease gene locus. Soc Neurosci Abstr 24 (1998) 813-818
7. Buxbaum J.D., Choi E.K., Luo Y., Lilliehook C., Crowley A.C., Merriam D.E., et al. Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat Med 4 (1998) 1177-1181
8. Carrion A.M., Mellstrom B., and Naranjo J.R. Protein kinase A-dependent derepression of the human prodynorphin gene via differential binding to an intragenic silencer element. Mol Cell Biol 18 (1998) 6921-6929
9. Carrion A.M., Link W.A., Ledo F., Mellstrom B., and Naranjo J.R. DREAM is a Ca2+-regulated transcriptional repressor. Nature 398 (1999) 80-84
10. Cheng H.Y., Pitcher G.M., Laviolette S.R., Whishaw I.Q., Tong K.I., Kockeritz L.K., et al. DREAM is a critical transcriptional repressor for pain modulation. Cell 108 (2002) 31-43
11. Dong X., Han S., Zylka M.J., Simon M.I., and Anderson D.J. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 106 (2001) 619-632
12. Draisci G., and Iadarola M.J. Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Brain Res Mol Brain Res 6 (1989) 31-37
13. Elshourbagy N.A., Ames R.S., Fizgerald L.R., Foley J.J., Chamers J.K., Szekeres P., et al. Receptor for the pain modulatory neuropeptides NPFF and NPAF is an orphan G-protein-coupled receptor. J Biol Chem 275 (2000) 25965-25971
14. Goetz J., Chatton B., Mattei M.G., and Kedinger C. Structure and expression of the ATFa gene. J Biol Chem 271 (1996) 29589-29598
15. Huang E.Y., Li J.Y., Tan P.P., Wong C.H., and Chen J.C. The cardiovascular effects of PFRFamide and PFR(Tic)amide, a possible agonist and antagonist of neuropeptide FF (NPFF). Peptides 21 (2000) 205-210
16. Iadarola M.J., Brady L.S., Draisci G., and Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain 35 (1988) 313-326
17. Jonsson J., Carlsson L., Edlund T., and Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371 (1994) 606-609
18. Kotani M., Mollereau C., Detheux M., Le Poul E., Brezillon S., Vakili J., et al. Functional characterization of a human receptor for neuropeptide FF and related peptides. Br J Pharmacol 133 (2001) 138-144
19. Kozak C.A., Gatignol A., Graham K., Jeang K.T., and McBride O.W. Genetic mapping in human and mouse of the locus encoding TRBP, a protein that binds the TAR region of the human immunodeficiency virus (HIV-1). Genomics 25 (1995) 66-72
20. Ledo F., Carrion A.M., Link W.A., Mellstrom B., and Naranjo J.R. DREAM-alphaCREM interaction via leucine-charged domains derepresses downstream regulatory element dependent transcription. Mol Cell Biol 20 (2000) 9120-9126
21. Lilliehook C., Bozdagi O., Yao J., Gomez-Ramirez M., Zaidi N.F., Wasco W., et al. Altered Aβ formation and long-term potentiation in a calsenilin knock-out. J Neurosci 23 (2003) 9097-9106
22. Lintunen M., Sallmen T., Karlstedt K., Fukui H., and Eriksson K.S. Panula P Postnatal expression of H1-receptor mRNA in the rat brain: correlation to l-histidine decarboxylase expression and local upregulation in limbic seizures. Eur J Neurosci 10 (1998) 2287-2301
23. Liu Q., Guan X.M., Martin W.J., McDonald T.P., Clements M.K., Jiang Q., et al. Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J Biol Chem 276 (2001) 36961-36969
24. MacArthur L., Ren K., Pfaffenroth E., Franklin E., and Ruda M.A. Descending modulation of opioid-containing nociceptive neurons in rats with peripheral inflammation and hyperalgesia. Neuroscience 88 (1999) 499-506
25. Maldonado E., Hampsey M., and Reinberg D. Repression: targeting the heart of the matter. Cell 99 (1999) 455-458
26. McFerran B.W., Weiss J.L., and Burgoyne R.D. Neuronal Ca(2+) sensor 1. Characterization of the myristoylated protein, its cellular effects in permeabilized adrenal chromaffin cells, Ca(2+)-independent membrane association, and interaction with binding proteins, suggesting a role in rapid Ca(2+) signal transduction. J Biol Chem 274 (1999) 30258-30265
27. Murase T., Arima H., Kondo K., and Oiso Y. Neuropeptide FF reduces food intake in rats. Peptides 17 (1996) 353-354
28. Naranjo J.R., Mellstrom B., Carrion A.M., Lucas J.J., Foulkes N.S., and Sassone-Corsi P. Peripheral noxious stimulation induces CREM expression in dorsal horn: involvement of glutamate. Eur J Neurosci 9 (1997) 2778-2783
29. Nicklous D.M., and Simansky K.J. Neuropeptide FF exerts pro- and anti-opioid actions in the parabrachial nucleus to modulate food intake. Am J Physiol Regul Integr Comp Physiol 285 (2003) R1046-R1054
30. Nieminen M.L., Brandt A., Pietilä P., and Panula P. Expression of mammalian RF-amide peptides neuropeptide FF (NPFF), prolactin-releasing peptide (PrRP) and the PrRP receptor in the peripheral tissues of the rat. Peptides 21 (2000) 1695-1701
31. Nieminen M.L., Nystedt J., and Panula P. Expression of neuropeptide FF, prolactin-releasing peptide, and the receptor UHR1/GPR10 genes during embryogenesis in the rat. Dev Dynam 226 (2003) 561-569
32. Nystedt J.M., Brandt A.M., Mandelin J., Vilim F.S., Ziff E.B., and Panula P. Analysis of human neuropeptide FF gene expression. J Neurochem 82 (2002) 1330-1342
33. Panula P., Aarnisalo A.A., and Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog Neurobiol 48 (1996) 461-487
34. Panula P., Kalso E., Nieminen M.L., Kontinen V., Brandt A., and Pertovaara A. Neuropeptide FF and modulation of pain. Brain Res 848 (1999) 191-196
35. Perry S.J., Yi-Kung H.E., Cronk C., Bagust J., Sharma R., Walker R.J., et al. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett 409 (1997) 426-430
36. Quinn J.P. Neuronal-specific gene expression - the interactions of both positive and negative transcriptional regulators. Prog Neurobiol 50 (1996) 363-379
37. Roumy M., Zajac J.M., and Neuropeptide F.F. Pain and analgesia. Eur J Pharmacol 345 (1998) 1-11
38. Roy R.J., Gosselin P., and Guerin S.L. A short protocol for micro-purification of nuclear proteins from whole animal tissue. Biotechniques 11 (1991) 770-777
39. Sanz C., Mellstrom B., Link W.A., Naranjo J.R., and Fernandez-Luna J.L. Interleukin 3-dependent activation of DREAM is involved in transcriptional silencing of the apoptotic Hrk gene in hematopoietic progenitor cells. EMBO J 20 (2001) 2286-2292
40. Spreafico F., Barski J.J., Farina C., and Meyer M. Mouse DREAM/calsenilin/KChIP3: gene structure, coding potential, and expression. Mol Cell Neurosci 17 (2001) 1-16
41. Sunter D., Hewson A.K., Lynam S., and Dickson S.L. Intracerebroventricular injection of neuropeptide FF, an opioid modulating neuropeptide, acutely reduces food intake and stimulates water intake in the rat. Neurosci Lett 313 (2001) 145-158
42. Torner L., Nava G., Duenas Z., Corbacho A., Mejia S., Lopez F., et al. Changes in the expression of neurohypophyseal prolactins during the estrous cycle and after estrogen treatment. J Endocrinol 161 (1999) 423-432
43. Vilim F.S., Aarnisalo A.A., Nieminen M.L., Lintunen M., Karlstedt K., Kontinen V.K., et al. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol Pharmacol 55 (1999) 804-811
44. Wierman M.E., Xiong X., Kepa J.K., Spaulding A.J., Jacobsen B.M., Fang Z., et al. Repression of gonadotropin-releasing hormone promoter activity by the POU homeodomain transcription factor SCIP/Oct-6/Tst-1: a regulatory mechanism of phenotype expression?. Mol Cell Biol 17 (1997) 1652-1665
45. Yang H.Y.T., Fratta W., Majane E.A., and Costa E. Isolation, sequencing, synthesis and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA 82 (1985) 7757-7761
46. Yang H.Y.T., and Iadarola M.J. Activation of spinal neuropeptide FF and the neuropeptide FF receptor 2 during inflammatory hyperalgesia in rats. Neuroscience 118 (2003) 179-187
47. Zaidi N.F., Berezovska O., Choi E.K., Miller J.S., Chan H., Lilliehook C., et al. Biochemical and immunocytochemical characterization of calsenilin in mouse brain. Neuroscience 114 (2002) 247-263